echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: Application of the 2021 EAN/PNS standard in chronic inflammatory demyelinating polyneuropathy

    JNNP: Application of the 2021 EAN/PNS standard in chronic inflammatory demyelinating polyneuropathy

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common immunodysfunctional neuropathy and usually occurs


    In this EAN/PNS guideline, electrodiagnostic support remains the primary diagnostic requirement for


     

    A retrospective study was conducted on 120 consecutive patients with clinical diagnosis of "suspected CIDP" and objective treatment response who attended the University Hospital of Birmingham in the UK to meet EAN/PNS 2021 criteria


    Standardized electrodiagnostic protocol

    The median, ulna, fibular and tibial motor nerves, as well as the median, ulnar, radial and sural sensory nerves, are studied


    Aggregate allocation of patient groups and standard satisfaction

    The sensitivity of the EAN/PNS standard to "CIDP" is 83.


    The sensitivity and specificity of the updated version of the EAN/PNS standard to clinical "suspected CIDP" is similar to that of previous versions


    There is a lack of reliable diagnostic biomarkers and no alternative diagnostic gold criteria


    The updated CIDP diagnostic criteria do not appear to be limited by the reduction in diagnostic categories, nor are they more sensitive or specific than older versions


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.